Bio-Path Holdings

Bio-Path Doses First Patient in Ph II Expansion Trial in Acute Myeloid Leukemia
CP Wire
Mon, 08/27/18 - 10:56 pm
Bio-Path Holdings
prexigebersen
acute myeloid leukemia
clinical trials
Bio-Path Doses First Patient in Ph II Expansion Trial in Acute Myeloid Leukemia
Mon, 08/27/18 - 09:49 am
Bio-Path Holdings
prexigebersen
acute myeloid leukemia